WILLIAM HAYDUK: Open Payments
NPI 1821363870 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,752 in 26 payments from 10 companies in 2025. Trend: 2023 $3,732 · 2024 $2,359 · 2025 $1,752
Food & beverage: $952Speaker / faculty: $800
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 7 | $1,186 |
| ABBVIE INC. | 4 | $185 |
| Pacira Pharmaceuticals Incorporated | 1 | $121 |
| Collegium Pharmaceutical, Inc. | 4 | $71 |
| PFIZER INC. | 3 | $52 |
| Electronic Waveform Lab, Inc. | 3 | $38 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $29 |
| DePuy Synthes Sales Inc. | 1 | $28 |
| Valinor Pharma, LLC | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: PROCLAIM, ETERNA, QULIPTA, Iovera, Belbuca, ZAVZPRET, JOURNAVX, MONOVISC.
Industry payments across IL — which companies pay providers there.
